Do you have the same question? Follow this Question
May 22, 2025 - 09:50 AM
We’ve provided several answers to questions related to Lariam (Mefloquine) , see some other helpful Q&A related to this product.
Question: Is this medication suitable for patients with a history of psychiatric disorders?
Answer: No, it should not be used for malaria prevention in patients with active or recent psychiatric disorders. This precaution helps prevent exacerbation of psychiatric symptoms, ensuring mental health safety.
Question: What are the active and inactive ingredients in this medication?
Answer: The active ingredient is mefloquine hydrochloride. Inactive ingredients include ammonium-calcium alginate, corn starch, crospovidone, lactose, magnesium stearate, microcrystalline cellulose, poloxamer #331, and talc. Knowing the ingredients helps identify potential allergens and ensures compatibility with patient needs.
Question: What is the recommended dosage for adults for malaria treatment?
Answer: Adults should take 5 tablets (1250 mg) by mouth one time with food and a full glass of water. This dosage is designed to effectively treat malaria while taking into account the body's absorption process.
Question: What is the elimination half-life of this medication?
Answer: The elimination half-life is approximately 2-4 weeks, with a mean of about 21 days. A longer half-life means the medication stays in the system longer, which is useful for preventing malaria over time with less frequent dosing.
Question: What is the strength of the tablets?
Answer: The tablets are available in 250 mg strength. This specific dosage allows for precise treatment and prevention of malaria, ensuring the effectiveness of the medication while minimizing potential side effects.
